Search Within

Chaitanya Divgi

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (7)
  2. Meeting Abstract (3)
Groups
  1. Department of Pathology and Laboratory Medicine (10)
  2. Molecular Imaging and Therapy Service (8)
  3. Radiology, Department of (8)
  4. Department of Medicine (7)
  5. Molecular Pharmacology and Chemistry Program Faculty (7)
  6. Sloan Kettering Institute Faculty (7)

More Groups

People
  1. Achim Jungbluth (7)
  2. Steven Larson (6)
  3. Lloyd Old (5)
  4. Neeta Pandit-Taskar (5)
  5. Ronald Finn (5)
  6. Andrew Nagel (4)

More People

Years
  1. 2011 (2)
  2. 2007 (3)
  3. 2006 (1)
  4. 2005 (1)
  5. 2004 (1)
  6. 2002 (1)

More Years

Publications
  1. Journal of Nuclear Medicine (4)
  2. Clinical Cancer Research (2)
  3. Journal of Clinical Oncology (2)
  4. Journal of Thoracic Oncology (1)
  5. Lancet Oncology (1)
Publishers
  1. Society of Nuclear Medicine (4)
  2. American Association for Cancer Research (2)
  3. American Society of Clinical Oncology (2)
  4. Elsevier Inc. (1)
  5. Elsevier Science, Inc. (1)

Results (10)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • (124)I-huA33 antibody uptake is driven by A33 antigen concentration in tissues from colorectal cancer patients imaged by immuno-PET
    Journal Article

    O'Donoghue, J. A.; Smith-Jones, P. M.; Humm, J. L.; Ruan, S.; Pryma, D. A.; Jungbluth, A. A.; Divgi, C. R.; Carrasquillo, J. A.; Pandit-Taskar, N.; Fong, Y.; more...
    Journal of Nuclear Medicine (2011)

    Fulltext@MSK | Save
  • (124)I-huA33 antibody PET of colorectal cancer
    Journal Article

    Carrasquillo, J. A.; Pandit-Taskar, N.; O'Donoghue, J. A.; Humm, J. L.; Zanzonico, P.; Smith-Jones, P. M.; Divgi, C. R.; Pryma, D. A.; Ruan, S.; Kemeny, N. E.; more...
    Journal of Nuclear Medicine (2011)

    Fulltext@MSK | Save
  • A phase II study of preoperative chemotherapy with irinotecan (CPT) and cisplatin (CIS) for gastric cancer (NCI 5917): FDG-PET/CT predicts patient outcome
    Meeting Abstract

    Shah, M. A.; Yeung, H.; Coit, D.; Trocola, R.; Ilson, D.; Randazzo, J.; Tang, L.; Brennan, M.; Divgi, C.; Kelsen, D. P.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Targeting Lewis Y (Le(y)) in small cell lung cancer with a humanized monoclonal antibody, hu3S193: A pilot trial testing two dose levels
    Journal Article

    Krug, L. M.; Milton, D. T.; Jungbluth, A. A.; Chen, L. C.; Quaia, E.; Pandit-Taskar, N.; Nagel, A.; Jones, J.; Kris, M. G.; Finn, R.; more...
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save
  • Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 ((124)I-cG250) and PET in patients with renal masses: a phase I trial
    Journal Article

    Divgi, C. R.; Pandit-Taskar, N.; Jungbluth, A. A.; Reuter, V. E.; Gonen, M.; Ruan, S.; Pierre, C.; Nagel, A.; Pryma, D. A.; Humm, J.; more...
    Lancet Oncology (2007)

    Fulltext@MSK | Save
  • Targeting Lewis Y (LeY) in small cell lung cancer (SCLC) with a humanized monoclonal antibody, hu3S193
    Meeting Abstract

    Krug, L. M.; Milton, D.; Chen, L.; Jungbluth, A. A.; Quaia, E.; Nagel, A.; Jones, J.; Finn, R.; Divgi, C.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Hu3S193, a humanized monoclonal antibody directed against Lewis Y, demonstrates strong targeting to small cell lung cancer (SCLC) in patients
    Meeting Abstract

    Krug, L. M.; Milton, D. T.; Chen, L. C.; Jungbluth, A. A.; Nagel, A.; Finn, R.; Pandit-Taskar, N.; Jones, J.; Divgi, C.
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save
  • Phase I clinical trial with fractionated radioimmunotherapy using (131)I-labeled chimeric G250 in metastatic renal cancer
    Journal Article

    Divgi, C. R.; O'Donoghue, J. A.; Welt, S.; O'Neel, J.; Finn, R.; Motzer, R. J.; Jungbluth, A.; Hoffman, E.; Ritter, G.; Larson, S. M.; more...
    Journal of Nuclear Medicine (2004)

    Fulltext@MSK | Save
  • A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation
    Journal Article

    Robbins, R. J.; Larson, S. M.; Sinha, N.; Shaha, A.; Divgi, C.; Pentlow, K. S.; Ghossein, R.; Tuttle, R. M.
    Journal of Nuclear Medicine (2002)

    Fulltext@MSK | Save
  • Interferon-γ and monoclonal antibody (131)I-labeled CC49: Outcomes in patients with androgen-independent prostate cancer
    Journal Article

    Slovin, S. F.; Scher, H. I.; Divgi, C. R.; Reuter, V.; Sgouros, G.; Moore, M.; Weingard, K.; Pettengall, R.; Imbriaco, M.; El-Shirbiny, A.; more...
    Clinical Cancer Research (1998)

    Fulltext@MSK | Save